A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
Clinical trial NCT05392114 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05392114
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-13
- Primary completion
- 2026-12-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.